Global Powered Morcellators Market Size By Type (LSH Morcellators, LM Morcellators), By Application (Gynecological Conditions, Digestive Tract Conditions), By Region, And Segment Forecasts, 2023 to 20...

The Global Powered Morcellators Market was valued at USD 1.1 billion in 2023 and is projected to surpass USD 1.82 billion by 2031, growing at a CAGR of 6.7% during the forecast period from 2023 to 2031. Powered morcellators are advanced surgical instruments widely used in minimally invasive gynecological and laparoscopic surgeries to divide and remove large tissue masses. The market is gaining traction due to the growing prevalence of uterine fibroids, rising demand for minimally invasive surgeries, and technological innovations in surgical tools.

Drivers:

1. Rising Demand for Minimally Invasive Procedures:

Minimally invasive surgeries offer advantages such as faster recovery, reduced hospital stays, and minimal scarring. This is boosting the adoption of powered morcellators across healthcare institutions worldwide.

2. Increasing Incidence of Uterine Fibroids and Other Gynecological Disorders:

The increasing number of women diagnosed with fibroids and related disorders is driving the need for effective tissue removal techniques, positioning powered morcellators as a preferred choice.

3. Technological Advancements in Surgical Instruments:

Continual enhancements in device precision, safety features, and integration with robotic surgical systems are improving the functionality of powered morcellators and expanding their use in complex procedures.

Restraints:

1. Regulatory Scrutiny and Legal Challenges:

Stringent regulatory guidelines, especially in the U.S. following FDA warnings, and ongoing litigations regarding the safety of morcellation in certain conditions are limiting market growth.

2. Risk of Cancerous Tissue Dissemination:

Concerns regarding the potential spread of undiagnosed malignant tissue during morcellation procedures have led to reduced adoption and increased demand for alternative techniques.

Opportunity:

1. Innovation in Contained Morcellation Systems:

The development of containment systems that minimize the risk of tissue dissemination is creating new opportunities for powered morcellator manufacturers to regain trust and increase usage.

2. Expansion in Emerging Markets:

The rise of healthcare infrastructure in developing nations and increasing awareness of minimally invasive procedures present significant growth potential for powered morcellators.

Market by System Type Insights:

Laparoscopic Morcellators accounted for the largest market share in 2023. Their compatibility with minimally invasive surgical techniques and widespread use in gynecology and urology make them the leading segment. Hysteroscopic Morcellators are projected to grow rapidly during the forecast period due to rising hysteroscopic surgeries and product innovation.

Market by End-use Insights:

Hospitals emerged as the largest end-use segment in 2023, representing over 55% of the market share. Hospitals are the primary sites for laparoscopic surgeries and possess advanced infrastructure and skilled professionals. Ambulatory Surgical Centers (ASCs) are anticipated to witness faster growth due to cost-effectiveness and increasing preference for outpatient procedures.

Market by Regional Insights:

North America dominated the market in 2023, driven by a high number of gynecological procedures, advanced healthcare infrastructure, and early adoption of new surgical tools. Asia-Pacific is expected to exhibit the fastest growth rate, attributed to rising healthcare investments, increasing medical tourism, and a growing female population with unmet medical needs.

Competitive Scenario:

Key players operating in the Global Powered Morcellators Market include Karl Storz GmbH & Co. KG, Olympus Corporation, Johnson & Johnson Services Inc., Richard Wolf GmbH, LiNA Medical USA, and Nouvag AG. These companies are focusing on enhancing product safety, innovating containment systems, and expanding into high-growth regions.

Key Developments:

In 2023, Olympus Corporation introduced a next-generation morcellator integrated with enhanced containment capability and improved ergonomic design.

In 2024, Johnson & Johnson received CE certification for its laparoscopic morcellation system with an advanced containment solution.

In 2025, Karl Storz announced its partnership with a U.S.-based health tech company to develop AI-assisted morcellation tools for precision gynecology.

Scope of Work – Global Powered Morcellators Market

Report Metric Details

Market Size (2023) USD 1.1 Billion

Projected Market Size (2031) USD 1.82 Billion

CAGR (2023–2031) 6.7%

Market Segments System Type (Laparoscopic, Hysteroscopic), End-use (Hospitals, ASCs), Region

Growth Drivers Demand for minimally invasive procedures, rising gynecological conditions

Opportunities Containment systems, emerging markets

FAQs:

1) What is the current market size of the Global Powered Morcellators Market?

The market size was valued at USD 1.1 billion in 2023.

2) What is the major growth driver of the Global Powered Morcellators Market?

The major driver is the increasing demand for minimally invasive surgical procedures.

3) Which is the largest region during the forecast period in the Global Powered Morcellators Market?

North America is projected to remain the leading region during the forecast period.

4) Which segment accounted for the largest market share in the Global Powered Morcellators Market?

Laparoscopic morcellators held the largest share in 2023.

5) Who are the key market players in the Global Powered Morcellators Market?

Key players include Karl Storz GmbH, Olympus Corporation, Johnson & Johnson, and Richard Wolf GmbH.